Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Elizabeth Richards

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
FDA, FDA and healthcare matters, FDA matters
Office
Washington D.C., Washington, D.C., Washington, DC
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsM&APrivate Equity & Buyouts
Sectors
Consumer & RetailHealthcare & Life SciencesIndustrials & ManufacturingTechnology
Jurisdictions
BelgiumCayman IslandsEuropean UnionFranceGermanyIrelandOhioSwedenTexasUnited KingdomUnited States

Recent deals

63 announced deals in the record
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 300m healthcare regulatory Washington, D.C.
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m regulatory Washington, D.C.
Latham & Watkins Advises LEO Pharma in Acquisition of Worldwide Rights to MC1R Agonist Dersimelagon 19 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP FDA Washington, D.C.
Latham & Watkins Advises Alkeus Pharmaceuticals on Acquisition by Tarsus Pharmaceuticals 10 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP regulatory
Latham & Watkins Advises Perceptive Advisors on Growth Financing for Leading Oncology Biotech Autolus Therapeutics 5 Aug 2026
Debt Capital Markets Healthcare & Life Sciences Latham & Watkins LLP USD 250m US healthcare regulatory
Latham & Watkins Advises Tempus AI on US$1.5 Billion Acquisition of Personalis 21 Jul 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 1.50bn FDA regulatory
Latham & Watkins Represents AtaiBeckley in Sale to Lilly 17 Jul 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP FDA/regulatory
Latham Advises on Kardigan’s US$460 Million IPO 30 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 460m FDA and healthcare matters
Latham Advises Mineralys Therapeutics in Unique Three-Pronged Transaction — Royalty Repurchase, Debt Financing, and Equity Offering — Totaling Up to US$950 Million 8 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 950m FDA matters
Latham Advises on Satellos’ US$50 Million Initial US Offering 10 Feb 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 50m FDA regulatory Washington, D.C.
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Elizabeth Richards is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 63 deals for Elizabeth Richards

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction